FDA Drug recall D-1188-2022
Morphine Sulfate extended-Release Tablets, USP
- FDA Drug
- Class I
- terminated
- Published 2022-07-20
On 2022-07-20 the FDA classified a Class I recall of Morphine Sulfate extended-Release Tablets, USP by Bryant Ranch Prepack, citing labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1188-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-06-17 |
| Published | 2022-07-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Bryant Ranch Prepack |
| Distribution | AL |
Product
Morphine Sulfate extended-Release Tablets, USP; 60 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., NJ; Relabeled by: Bryant Ranch Prepack, Inc, CA, NDC 63629-1089-01
Reason
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Identifiers
| code_info | Lot #: 179643, Exp. Date 08/31/2023. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1188-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.